by Rachel Gauvin | Sep 21, 2020
We are honored to be featured in an interview with Bioinformant! Disrupting the Cell Therapy Market: Nucleus Biologics Brings Transparency, Customization & Control In recent years, the cell culture company Nucleus Biologics has been at the forefront...
by Dr. Alyssa Master | May 27, 2020
SAN DIEGO, May 27, 2020 — Nucleus Biologics, a leader in precision cell culture, today announced the availability of NB-Lux™, an online configuration and ordering platform for cell culture media. Designed for developers of cell therapies, NB-Lux™ speeds...
by Dr. Alyssa Master | Sep 25, 2019
SAN DIEGO – September 25, 2019 – Nucleus Biologics™, a leader in precision cell culture, has announced the broader launch of Concierge™ Media Manufacturing Services. This offering fits Nucleus Biologics’™ mission “to speed the time from discovery to cure” by offering...
by Dr. Alyssa Master | Aug 5, 2019
Nucleus Biologics™ now has the leading xeno-free, recombinant, extracellular matrix SAN DIEGO – August 6, 2019 – Nucleus Biologics™, a leader in precision cell culture, is pleased to announce the acquisition of Primorigen Biosciences, Inc. The addition...
by Dr. Alyssa Master | Sep 20, 2018
For immediate release Nucleus Biologics Joins Cell Manufacturing Research Initiative SAN DIEGO – SEPTEMBER 20, 2018 – Nucleus Biologics is pleased to announce it has joined the new NSF Engineering Research Center for Cell Manufacturing Technologies, known as CMaT. The...
by Dr. Alyssa Master | Aug 10, 2018
Nucleus Biologics encourages researchers to pursue excellence in their experimental reproducibility. We are pleased to announce that the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network has selected us as an approved supplier for...
